Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Gianellini

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2025
A Robust siRNA Screening Approach with Optimized Conditions for Large-Scale Transfection in Multiple Human Cancer Cell LinesFabio Gasparri, Ivan Fraietta, Laura Gianellini, et al.
The Journal of Biological Chemistry|February 24, 2010
Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinaseClaudia Perrera, Riccardo Colombo, Barbara Valsasina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activityChiara Soncini, Patrizia Carpinelli, Laura Gianellini, et al.
Molecular Cancer Therapeutics|December 20, 2007
PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancerPatrizia Carpinelli, Roberta Ceruti, Maria Laura Giorgini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2013
NMS-E973, a novel synthetic inhibitor of Hsp90 with activity against multiple models of drug resistance to targeted agents, including intracranial metastasesGianpaolo Fogliatto, Laura Gianellini, Maria G Brasca, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|March 31, 2025
A Robust siRNA Screening Approach with Optimized Conditions for Large-Scale Transfection in Multiple Human Cancer Cell LinesFabio Gasparri, Ivan Fraietta, Laura Gianellini, et al.
The Journal of Biological Chemistry|February 24, 2010
Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinaseClaudia Perrera, Riccardo Colombo, Barbara Valsasina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activityChiara Soncini, Patrizia Carpinelli, Laura Gianellini, et al.
Molecular Cancer Therapeutics|December 20, 2007
PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancerPatrizia Carpinelli, Roberta Ceruti, Maria Laura Giorgini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2013
NMS-E973, a novel synthetic inhibitor of Hsp90 with activity against multiple models of drug resistance to targeted agents, including intracranial metastasesGianpaolo Fogliatto, Laura Gianellini, Maria G Brasca, et al.
Pageof 1